Akso Health Group reported its unaudited financial results for the six months ended September 30, 2025. The company posted revenues of USD 7.00 million for the period. Net revenues stood at USD 7.00 million, while cost of revenue was USD 6.38 million. The company reported a comprehensive loss attributable to shareholders of USD 0.84 million for the half-year period. Basic and diluted net loss per share were both reported at USD 0.001. Weighted average shares outstanding for the period were 1,767,296,875. As of September 30, 2025, Akso Health Group held cash and cash equivalents of USD 11.13 million, compared to USD 176.23 million at the beginning of the period. Total equity at the end of the period was USD 198.31 million, while total liabilities and shareholders’ equity reached USD 212.04 million. Akso Health Group, previously known as Xiaobai Maimai Inc., is incorporated in the Cayman Islands. The company and its subsidiaries have transitioned from operating an online peer-to-peer marketplace and micro-lending business in China. The company is not subject to income taxes in the Cayman Islands and has subsidiaries in Hong Kong and the United States, with varying tax obligations based on jurisdiction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akso Health Group published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-014261), on February 10, 2026, and is solely responsible for the information contained therein.